Literature DB >> 3658081

Prevalence studies of multiple sclerosis, myasthenia gravis, and myopathies in Kumamoto district, Japan.

S Araki1, M Uchino, T Kumamoto.   

Abstract

The prevalence ratio per 100,000 population of each disease was multiple sclerosis (MS) 1.3, myasthenia gravis (MG) 6.7, and polymyositis (PM) 5.0 in Kumamoto city, Japan (population 0.56 million, and the survey date on June 30, 1982). The prevalence ratio of MS was similar to that of 25 years ago in Kumamoto city. The incidence of MS had been stable despite Westernization of life-style in Japan. The prevalence ratio of MG and PM had increased moderately, possibly due to prolongation of life with recent progress in therapy. The prevalence ratio of all types of myopathies in Kumamoto prefecture (population: 1.8 million) on July 31, 1983, was estimated as approximately 17.4 per 100,000, for progressive muscular dystrophy (PMD) 4.1 per 100,000 population, compared to 3.9 for MG, and 2.4 for PM. The relative frequency of PMD, MG and PM was 23.3, 22.0 and 13.9%, respectively. The data shows that the prevalence ratio of various myopathies has not changed over the last 20 years in selected cities of Japan but the relative frequency of the diseases have changed due to recognition of the disease and prolongation of long life due to developments in diagnosis and treatment.

Entities:  

Mesh:

Year:  1987        PMID: 3658081     DOI: 10.1159/000110107

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  6 in total

1.  Epidemiological study of myasthenia gravis in the province of Ferrara, Italy.

Authors:  M R Tola; E Granieri; E Paolino; L Caniatti; R Quatrale; B Mazzanti; R D'Alessandro
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

2.  Clinical, electrophysiologic, and histopathologic profile, and outcome in idiopathic inflammatory myositis: An analysis of 68 cases.

Authors:  K N Ramesha; Abraham Kuruvilla; P S Sarma; V V Radhakrishnan
Journal:  Ann Indian Acad Neurol       Date:  2010-10       Impact factor: 1.383

3.  Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.

Authors:  Soo-Kyung Cho; Hyoungyoung Kim; Jisun Myung; Eunwoo Nam; Sun-Young Jung; Eun Jin Jang; Dae-Hyun Yoo; Yoon-Kyoung Sung
Journal:  J Korean Med Sci       Date:  2019-02-08       Impact factor: 2.153

4.  Prevalence and disease progression of genetically-confirmed facioscapulohumeral muscular dystrophy type 1 (FSHD1) in China between 2001 and 2020: a nationwide population-based study.

Authors:  Zhiqiang Wang; Liangliang Qiu; Minting Lin; Long Chen; Fuze Zheng; Lin Lin; Feng Lin; Zhixian Ye; Xiaodan Lin; Junjie He; Lili Wang; Xin Lin; Qifang He; Wanjin Chen; Yi Lin; Ying Fu; Ning Wang
Journal:  Lancet Reg Health West Pac       Date:  2021-11-22

5.  Joining mainstream research on Facioscapulohumeral Dystophy: disease prevalence in China.

Authors:  Frédérique Magdinier
Journal:  Lancet Reg Health West Pac       Date:  2021-12-11

6.  Multiple Sclerosis in the Asia Pacific Region: A Systematic Review of a Neglected Neurological Disease.

Authors:  Wing L Cheong; Devi Mohan; Narelle Warren; Daniel D Reidpath
Journal:  Front Neurol       Date:  2018-06-08       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.